Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF227 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | ING4 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | GSK3B | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | JTB | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
mRNA | TSHZ1 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | ZNF660 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-07 |
mRNA | FAM13C | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | ZNF70 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | PHLPP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | TP73 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |